Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-24

FDA Approved: SILDENAFIL — Supplemental Application (Quallent Pharmaceuticals Health LLC)

View source ↗

Summary

FDA approved a supplemental application for sildenafil submitted by Quallent Pharmaceuticals Health LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SILDENAFIL (SILDENAFIL)

Snippet

SUPPL AP for SILDENAFIL (SILDENAFIL)